穿戴式心脏复律除颤器在乳房切除术后放疗中作为脉冲发生器移位替代方案的应用
本文报告一例植入式心脏复律除颤器(ICD)部分位于靶区内、计划系统预估最大剂量约36 Gy的乳腺癌患者,在乳房切除术后腋窝放疗期间关闭ICD放电功能,改用穿戴式心脏复律除颤器(WCD)覆盖3周放疗期及治疗结束后2周,患者耐受良好,ICD及电池在治疗开始至治疗后6个月监测期间功能正常。
要点
- ICD部分位于靶区内,计划系统预估最大剂量约36 Gy。
- 术后伤口感染需手术干预及3个月抗生素,决定不移位ICD而是关闭放电功能。
- WCD在3周放疗期间及治疗结束后2周佩戴,患者耐受良好。
核心结论
- 在ICD需要半永久性关闭的情况下,WCD可作为替代方案。
- 本报告患者对WCD耐受良好。
- 尽管ICD接受高剂量照射,装置及其电池仍继续正常功能。
研究设计与样本
- 本文为病例报告,描述一例植入ICD的乳腺癌患者接受乳房切除术后及腋窝放疗。
主要发现
- ICD部分位于靶区内,按治疗计划系统将接受最大剂量约36 Gy。
- 术后患者发生伤口感染,需手术干预及3个月抗生素治疗。
- 决定不移位ICD,而是在整个放疗疗程中关闭ICD的放电功能。
- ICD被WCD成功替代,患者在3周放疗期间佩戴WCD直至治疗结束后2周。
- ICD功能从治疗开始监测至治疗结束后6个月,装置及电池继续正常功能。
临床怎么用
- 作者报告在ICD需半永久性关闭的情况下,WCD可作为替代方案。
- 本报告患者在放疗期间及治疗结束后2周佩戴WCD,耐受良好。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We describe a case in which a breast cancer patient with an implantable cardioverter-defibrillator (ICD) was treated with postmastectomy followed by axillary radiation therapy. The ICD was partly within the target volume and according to the treatment planning system would receive a maximum dose of about 36 Gy. METHODS AND MATERIALS: Postoperatively, the patient had a wound infection needing surgical intervention and 3 months of antibiotics. Therefore, it was decided not to relocate the ICD but instead to switch off the shock function of the ICD for the entire radiation therapy course. RESULTS: The ICD was successfully substituted with a wearable cardioverter defibrillator (WCD), which the patient wore during the 3-week radiation therapy period until 2 weeks after the end of treatment. The ICD function was monitored from the start of the treatment until 6 months after treatment. CONCLUSIONS: In situations in which an ICD needs to be switched off semipermanently, a WCD can be used as alternative. The patient in this report tolerated the WCD well. Despite the high dose received by the ICD, the device and its battery continued to function normally.
引用
- Koken PW, van den Bongard DHJG, Kooiman KM, et al. The use of a wearable cardioverter defibrillator during postmastectomy radiotherapy as an alternative for relocation of the pulse generator. Adv Radiat Oncol. 2023. PMID: 37168315. doi:10.1016/j.adro.2023.101225
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。